Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its ...
A brain-computer interface helped restore movement and sensation in a 48-year old man with quadriplegia, researchers say.
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...
Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more
Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory ...
Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of ...
John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — A Senate vote to halt ...
Erica Schwartz and Sean Kaufman navigated tough questions about vaccines, political independence, and pushing back on RFK Jr.
CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient ...
A trio of bipartisan lawmakers reintroduced a bill requiring the FTC and Treasury to investigate whether the U.S. relies too ...
Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens ...
Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC.
When the body’s most important blood vessel tears from the inside, it’s a medical emergency that can be years in the making.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results